GNTA logo

Genenta Science SpA (GNTA)

Profile

Full Name

Genenta Science S.p.A.

Ticker Symbol

GNTA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Italy

IPO

December 15, 2021

Indexes

Not included

Website

http://www.genenta.com

Employees

13

Key Details

Price

$3.69(-4.87%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.53(+23.45% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.69
GNTA price is $3.69

30-Day Relative Volume

0.29
GNTA 30-day relative volume is 0.29

Price Performance

Price Most recent change

-4.87%
GNTA price was down -4.87% on Apr 17, 2025

Price YTD change

-15.17%
GNTA price is down -15.17% since January 1st

Price 1-year change

+23%
GNTA price is up +23% year-on-year

Price 3-year change

-42.7%
GNTA price is down -42.7% over the past 3 years

Price Range

Price All-time high

$13.13
GNTA price is currently -71.90% below its historical high of $13.13

Price 3-year low

$2.20
GNTA price is currently +67.73% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$67.49M
GNTA market capitalization is $67.49 million

Market cap 3-year change

-42.47%
GNTA market capitalization is down -42.47% over the past 3 years

Market cap All-time high

$215.09M
GNTA market capitalization is currently -68.62% below its historical high of $215.09 million

Market cap sector rank

42.6%
GNTA market capitalization is higher than 42.6% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.4%
GNTA shares outstanding is up +0.4% year-on-year

Shares Outstanding 3-Year Change

+0.4%
GNTA shares outstanding is up +0.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.19
GNTA beta is 0.19

200-day SMA

$4.35
GNTA price is currently -15.08% below its 200-day simple moving average

50-day SMA

$3.88
GNTA price is currently -4.80% below its 50-day simple moving average

RSI

45.17
GNTA 14-day relative strength index is 45.17

Volume

0.29
GNTA 30-day relative volume is 0.29

ATR

$0.33
GNTA average true range is $0.33

10-day Historical Volatility

73.28%
GNTA 10-day historical volatility is 73.28%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
GNTA annual revenue value is unknown

Revenue Analysts estimate

-
GNTA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
GNTA annual revenue 1-year change is unknown

Revenue Sector rank

-
GNTA annual revenue is unknown

EPS

EPS

-$0.53
GNTA annual earnings per share is -$0.53

EPS Analysts estimate

-$0.71
GNTA annual earnings per share is currently -25.30% lower than the consensus analysts' forecast

EPS 1-year change

+23.45%
GNTA annual earnings per share is up +23.45% year-on-year

EPS Sector rank

67.52%
GNTA annual earnings per share is higher than 67.52% of companies in Healthcare sector

Profit

Gross profit

-
GNTA annual gross profit value is unknown

Gross margin

-
GNTA annual gross profit margin value is unknown

Operating profit

-$10.57M
GNTA annual operating income is -$10.57 million

Operating margin

-
GNTA annual operating profit margin value is unknown

Net income

-$9.65M
GNTA annual net profit is -$9.65 million

Net margin

-
GNTA annual net profit margin value is unknown

Expenses

Total expenses

$10.57M
GNTA annual total expenses is $10.57 million

Operating expenses

$10.57M
GNTA annual total operating expenses is $10.57 million

Cost of goods sold

-
GNTA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$5.36M
GNTA annual SGA is $5.36 million

Depreciation and amortization

$48.20K
GNTA annual depreciation & amortization is $48.20 thousand

Interest expense

-
GNTA annual interest expense value is unknown

Income tax

$0.00
GNTA annual income tax is $0.00

EBIT & EBITDA

EBIT

-$10.57M
GNTA annual earnings before interest & taxes is -$10.57 million

EBITDA

-$10.52M
GNTA annual EBITDA is -$10.52 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$15.43M
GNTA annual total assets is $15.43 million

Non current assets

$365.30K
GNTA annual long term assets is $365.30 thousand

Current assets

$15.06M
GNTA annual total current assets is $15.06 million

Cash and cash equivalents

$4.77M
GNTA annual cash & cash equivalents is $4.77 million

Accounts receivable

-
GNTA annual accounts receivable value is unknown

Inventory

-
GNTA annual inventory value is unknown

Liabilities

Total liabilities

$2.42M
GNTA annual total liabilities is $2.42 million

Long term liabilities

$238.20K
GNTA annual total long term liabilities is $238.20 thousand

Current liabilities

$2.18M
GNTA annual total current liabilities is $2.18 million

Accounts payable

$330.70K
GNTA annual accounts payable is $330.70 thousand

Debt

Total debt

$0.00
GNTA annual total debt is $0.00

Total debt 1-year change

0%
GNTA {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
GNTA annual long term debt value is unknown

Short term debt

-
GNTA annual short term debt value is unknown

Equity & Capital

Shareholders equity

$13.00M
GNTA annual stockholders equity is $13.00 million

Book value

$13.00M
GNTA annual book value is $13.00 million

Retained earnings

-$58.33M
GNTA annual retained earnings is -$58.33 million

Working capital

$12.88M
GNTA annual working capital is $12.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.75M
GNTA annual cash flow from operations is -$6.75 million

Cash from operations 1-year change

+44.32%
GNTA annual cash flow from operations is up +44.32% year-on-year

Cash from investing

$7.45M
GNTA annual cash flow from investing activities is $7.45 million

Cash from investing 1-year change

+146.21%
GNTA annual cash flow from investing activities is up +146.21% year-on-year

Cash from financing

$293.20K
GNTA annual cash flow from financing activities is $293.20 thousand

Cash from financing 1-year change

+48766.67%
GNTA annual cash flow from financing activities is up +48766.67% year-on-year

CAPEX

CAPEX

-
GNTA annual capital expenditures value is unknown

CAPEX 1-year change

-
GNTA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$6.76M
GNTA annual free cash flow is -$6.76 million

Free cash flow 1-year change

+44.35%
GNTA annual free cash flow is up +44.35% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
GNTA annual gross profit margin value is unknown

Operating margin

-
GNTA annual operating profit margin value is unknown

Net margin

-
GNTA annual net profit margin value is unknown

ROA & ROE

ROA

-62.54%
GNTA annual return on assets is -62.54%

ROE

-74.19%
GNTA annual return on equity is -74.19%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
GNTA price to earnings ratio value is unknown

PE ratio Sector rank

-
GNTA price to earnings ratio is unknown

PB Ratio

PB ratio

5.19
GNTA price to book ratio is 5.19

PB ratio Sector rank

83.94%
GNTA price to book ratio is higher than 83.94% of companies in Healthcare sector

PS Ratio

PS ratio

-
GNTA price to sales ratio value is unknown

PS ratio Sector rank

-
GNTA price to sales ratio is unknown

Enterprise value

Enterprise value

$62.72M
GNTA enterprise value is $62.72 million

Enterprise value Sector rank

44.51%
GNTA enterprise value is higher than 44.51% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
GNTA EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
GNTA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.89
GNTA annual current ratio is 6.89

Quick ratio

-
GNTA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
GNTA annual debt to equity ratio is 0.00

Interest coverage ratio

-
GNTA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
GNTA piotroski f-score value is unknown

Altman Z-Score

-
GNTA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Oct 2, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Feb 8, 23 HC Wainwright & Co.
Buy
Jan 5, 23 EF Hutton
Buy
Jul 25, 22 HC Wainwright & Co.
Buy
Jan 13, 22 Maxim Group
Buy

Institutional Ownership

Similar stocks

Alpha Cognition (ACOG)
CRBU logo
Caribou Biosciences (CRBU)
CPIX logo
Cumberland Pharmaceuticals (CPIX)
CLSD logo
Clearside Biomedical (CLSD)
IMAB logo
I-Mab (IMAB)
ACHV logo
Achieve Life Sciences (ACHV)
ICCM logo
IceCure Medical Ltd (ICCM)
SAVA logo
Cassava Sciences (SAVA)
ZYXI logo
Zynex (ZYXI)
  • What is the ticker symbol for Genenta Science SpA?
  • Does Genenta Science SpA pay dividends?
  • What sector is Genenta Science SpA in?
  • What industry is Genenta Science SpA in?
  • What country is Genenta Science SpA based in?
  • When did Genenta Science SpA go public?
  • Is Genenta Science SpA in the S&P 500?
  • Is Genenta Science SpA in the NASDAQ 100?
  • Is Genenta Science SpA in the Dow Jones?
  • When was Genenta Science SpA's last earnings report?
  • When does Genenta Science SpA report earnings?

What is the ticker symbol for Genenta Science SpA?

The ticker symbol for Genenta Science SpA is NASDAQ:GNTA

Does Genenta Science SpA pay dividends?

No, Genenta Science SpA does not pay dividends

What sector is Genenta Science SpA in?

Genenta Science SpA is in the Healthcare sector

What industry is Genenta Science SpA in?

Genenta Science SpA is in the Biotechnology industry

What country is Genenta Science SpA based in?

Genenta Science SpA is headquartered in Italy

When did Genenta Science SpA go public?

Genenta Science SpA's initial public offering (IPO) was on December 15, 2021

Is Genenta Science SpA in the S&P 500?

No, Genenta Science SpA is not included in the S&P 500 index

Is Genenta Science SpA in the NASDAQ 100?

No, Genenta Science SpA is not included in the NASDAQ 100 index

Is Genenta Science SpA in the Dow Jones?

No, Genenta Science SpA is not included in the Dow Jones index

When was Genenta Science SpA's last earnings report?

Genenta Science SpA's most recent earnings report was on Apr 26, 2023

When does Genenta Science SpA report earnings?

The date for Genenta Science SpA's next earnings report has not been announced yet
On this page